Importantly, RAR activation promotes, whereas ERK activation suppresses, differentiation of CRC cells, suggesting a role of antagonistic interactions between ERK and RAR signaling in CRC cell fate decisions [17]. The gene discussed is RARA; the disease is colorectal carcinoma.